Pudendal Block Using Liposomal Bupivacaine vs. Standard Treatment During Sacrospinous Ligament Fixation

PHASE4UnknownINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

September 24, 2018

Primary Completion Date

December 1, 2021

Study Completion Date

December 1, 2021

Conditions
Vaginal Prolapse
Interventions
DRUG

Liposomal Bupivacaine

The objective of our study is to compare the use of EXPAREL in minimizing post-operative pain after sacrospinous ligament fixation with or without concomitant procedures for pelvic organ prolapse, with or without suburethral sling. We hypothesize that pudendal nerve blockage using long-acting EXPAREL will reduce post-operative pain and potentially reduce oral narcotic consumption. It may also reduce the incidence of postoperative constipation and patient satisfaction.

Trial Locations (1)

07960

RECRUITING

Atlantic Health System, Morristown

Sponsors
All Listed Sponsors
lead

Atlantic Health System

OTHER